TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28591675

Group type: EXPERIMENTAL
Intervention: Ramucirumab (8 mg/kg)
Number of subjects: 565

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 565
Study: 25628283

Group type: EXPERIMENTAL
Intervention: Proximal Chevron osteotomy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Distal Chevron osteotomy
Number of subjects: 46
Study: 23876463

Group type: EXPERIMENTAL
Intervention: Intensive glycemic control (IGC) for almost 24 h after PCI (n = 54; target glucose 80-140 mg/dl)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Conventional glycemic control (CGC) (n = 52; target glucose 180-200 mg/dl)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Intensive glycemic control (IGC)
Number of subjects: 194
Study: 21654268

Group type: EXPERIMENTAL
Intervention: Febuxostat 80 mg/d
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Febuxostat 60 mg/d
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Febuxostat 40 mg/d
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Febuxostat 20 mg/d
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Febuxostat (all doses)
Number of subjects: 202
Study: 19261960

Group type: EXPERIMENTAL
Intervention: Subcutaneous tramadol infiltration
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous tramadol administration
Number of subjects: 60
Study: 16357094

Group type: EXPERIMENTAL
Intervention: High-sodium diet (250 mmol/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low-sodium diet (70 mmol/day)
Number of subjects: 24
Study: 15310527

Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin daily for 24 weeks
Number of subjects: 106
Study: 11710656

Group type: EXPERIMENTAL
Intervention: Superslow (SS) strength training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Traditional Nautilus-style (TR) strength training
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups (SS and TR)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Strength training alone
Number of subjects: 14
Study: 9412311

Group type: EXPERIMENTAL
Intervention: Vitamin B6, 50 mg/d
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Folic acid, 5 mg/d, and vitamin B12, 0.4 mg/d
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Vitamin B6, 50 mg/d, folic acid, 5 mg/d, and vitamin B12, 0.4 mg/d
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 8174540

Group type: EXPERIMENTAL
Intervention: Fentanyl 1.5 microgram kg‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: No fentanyl (Control)
Number of subjects: 20
Study: 3146370

Group type: EXPERIMENTAL
Intervention: Intravenous recombinant tissue plasminogen activator (100 mg over three hours)
Number of subjects: 721

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 721
Study: 30221006

Group type: EXPERIMENTAL
Intervention: Immediate-release metformin 250 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Immediate-release metformin 500 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Immediate-release metformin 1000 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 18
Study: 28393817

Group type: EXPERIMENTAL
Intervention: 0.6% triphala
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 26084514

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine (Gardasil)
Number of subjects: 1598
Study: 23932956

Group type: EXPERIMENTAL
Intervention: Massage therapy by mothers
Number of subjects: 66
Study: 21812879

Group type: EXPERIMENTAL
Intervention: Self-efficacy program + standard diabetes education program
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (standard diabetes education program only)
Number of subjects: 145
Study: 19564902

Group type: EXPERIMENTAL
Intervention: Pralidoxime (2 g loading dose over 20 min, followed by 0.5 g/h for up to 7 days)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Pralidoxime
Number of subjects: 235
Study: 16724996

Group type: COMPARATOR
Intervention: Gabexate mesilate (900 mg)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: High-dose ulinastatin (450,000 units)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Low-dose ulinastatin (150,000 units)
Number of subjects: 139
Study: 14655042

Group type: EXPERIMENTAL
Intervention: SCPC abstracts
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Descriptive studies
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Treatment outcomes
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Health services research
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Literature reviews
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Bone metastases
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Primary lung tumors
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Brain metastases
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Dedicated palliative radiotherapy clinics
Number of subjects: 892
Study: 11291347

Group type: EXPERIMENTAL
Intervention: Silicone tubes used to enclose the injured zone of transsected ulnar and median nerves
Number of subjects: 7

Group type: COMPARATOR
Intervention: Conventional microsurgical repair of the nerve trunk
Number of subjects: 7
Study: 9423911

Group type: EXPERIMENTAL
Intervention: All-suture release (ASR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Selective suture release (SSR)
Number of subjects: 30
Study: 8487666

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (200 mg/wk intramuscularly)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Testolactone (250 mg four times per day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combined testosterone and testolactone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 14
Study: 3232537

Group type: EXPERIMENTAL
Intervention: Test drug (2 different doses)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Combined group (test drug and placebo)
Number of subjects: 57
Study: 31928490

Group type: EXPERIMENTAL
Intervention: Oily dispersion of EGCG complexed with NOPE
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 29298660

Group type: EXPERIMENTAL
Intervention: Fractionated stereotactic radiotherapy to the resection cavity (total dose of 46 Gy in 2 Gy per fraction or 36 Gy in 3 Gy per fraction)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 0
Study: 27521557

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 772

Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 772
Study: 24569129

Group type: EXPERIMENTAL
Intervention: QVA149 (440/200 μg)
Number of subjects: 50
Study: 23699763

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (0.5 μg/kg/min for 4 hours)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20482496

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (no SMBG)
Number of subjects: 500
Study: 18427133

Group type: EXPERIMENTAL
Intervention: Ramipril (2.5 to 10 mg) for 8 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 21485725

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 16048650

Group type: EXPERIMENTAL
Intervention: trimethoprim/sulfamethoxazole 1 double-strength tablet twice daily for 3 days
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: ciprofloxacin 250 mg twice daily for 3 days
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: nitrofurantoin 100 mg twice daily for 7 days
Number of subjects: 157
Study: 12373371

Group type: EXPERIMENTAL
Intervention: Light touch to the head or neck
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finger fixed in a clip
Number of subjects: 0

Group type: COMPARATOR
Intervention: Free light touch to a pad
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contact with load via pulley system
Number of subjects: 0
Study: 9533391

Group type: EXPERIMENTAL
Intervention: Kanji (morphograms)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Kana (syllabograms)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alphabet letters
Number of subjects: 6
Study: 7541860

Group type: EXPERIMENTAL
Intervention: 560 mg estramustine phosphate daily for 6 weeks preoperatively
Number of subjects: 130

Group type: COMPARATOR
Intervention: Immediate radical prostatectomy
Number of subjects: 130
Study: 2612166

Group type: EXPERIMENTAL
Intervention: Formulation A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formulation B
Number of subjects: 0
Study: 849020

Group type: EXPERIMENTAL
Intervention: Metrifonate (Bilarcil Bayer AG) at a dose rate of 7.5 mg/kg once per fortnight for three doses during therapy stage and four-weekly during prophylaxis stage.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metrifonate (Bilarcil Bayer AG)
Number of subjects: 0
Study: 11590479

Group type: EXPERIMENTAL
Intervention: Arm training (AG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Leg training (LG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 15
Study: 29800423

Group type: EXPERIMENTAL
Intervention: Prescriptive implementation of DPA during instructional time (n = 88)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Nonprescriptive implementation of DPA during noninstructional time (n = 23)
Number of subjects: 111
Study: 29078230

Group type: EXPERIMENTAL
Intervention: Digital device (group D)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Water seal (group E)
Number of subjects: 95
Study: 26278675

Group type: EXPERIMENTAL
Intervention: Closed suction drainage (CSD), n = 44
Number of subjects: 88

Group type: COMPARATOR
Intervention: No closed suction drainage, n = 44
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Closed suction drainage (CSD)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No closed suction drainage
Number of subjects: 88
Study: 25403298

Group type: EXPERIMENTAL
Intervention: Phenotropil (12 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Pantogam active
Number of subjects: 70
Study: 23018373

Group type: EXPERIMENTAL
Intervention: Smaller ring group
Number of subjects: 74
Study: 20395896

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with ropivacaine and sufentanil
Number of subjects: 120
Study: 17906185

Group type: EXPERIMENTAL
Intervention: Chickpea diet (canned drained chickpeas, bread, and shortbread biscuits containing 30% chickpea flour)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Wheat-based diet (high-fibre wheat breakfast cereals and wholemeal bread)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Chickpea diet
Number of subjects: 27

Group type: COMPARATOR
Intervention: Lower-fibre wheat diet (low-fibre breakfast cereals and bread)
Number of subjects: 27
Study: 16162713

Group type: EXPERIMENTAL
Intervention: Aqueous 0.03% nasal ipratropium
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal saline solution placebo
Number of subjects: 10
Study: 13679971

Group type: EXPERIMENTAL
Intervention: Grouped dosage of immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional dosage of immunotherapy
Number of subjects: 0
Study: 10097931

Group type: EXPERIMENTAL
Intervention: Lispro + NPH
Number of subjects: 56

Group type: COMPARATOR
Intervention: Hum-R (Control)
Number of subjects: 56
Study: 9124984

Group type: EXPERIMENTAL
Intervention: Cefpirome
Number of subjects: 123
Study: 2065403

Group type: EXPERIMENTAL
Intervention: Oral iron supplementation every day for three months (G1)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo (G2)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Daily iron supplementation for anaemic infants (G3)
Number of subjects: 241
Study: 6562280

Group type: EXPERIMENTAL
Intervention: Polyacrilonitrile membrane
Number of subjects: 4

Group type: COMPARATOR
Intervention: Cellulose hydrate, cuprophan, cellulose acetate, and polyacrilonitrile membranes
Number of subjects: 4
Study: 31036058

Group type: EXPERIMENTAL
Intervention: Integrative improvisational music therapy (IIMT) alone
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Integrative improvisational music therapy (IIMT) with home‐based listening (LH)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Integrative improvisational music therapy (IIMT) with resonance frequency breathing (RFB)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Integrative improvisational music therapy (IIMT) with both enhancements (LH and RFB)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Self-rated momentary depression level before every IIMT session
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Homework compliance in IIMT + LH
Number of subjects: 68
Study: 30074418

Group type: EXPERIMENTAL
Intervention: Severe hematologic toxicity (CTCAE grade 3–4)
Number of subjects: 873

Group type: COMPARATOR
Intervention: Non-severe hematologic toxicity (CTCAE grade 0–2)
Number of subjects: 873
Study: 26961928

Group type: EXPERIMENTAL
Intervention: High dietary intake of folate
Number of subjects: 2525

Group type: EXPERIMENTAL
Intervention: High dietary intake of thiamin
Number of subjects: 2525

Group type: EXPERIMENTAL
Intervention: High dietary intake of riboflavin
Number of subjects: 2525

Group type: EXPERIMENTAL
Intervention: Folate and B vitamins
Number of subjects: 2525
Study: 24446891

Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BV)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Left ventricular only pacing (LV)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Atrial pacing (AP) with BV
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Atrial pacing (AP) with LV
Number of subjects: 31
Study: 22732975

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum CECT 7315/7316 (5*10^9 cfu/day) in 20 g powdered skim milk
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum CECT 7315/7316 (5*10^8 cfu/day) in 20 g powdered skim milk
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (20 g powdered skim milk)
Number of subjects: 60
Study: 20088984

Group type: EXPERIMENTAL
Intervention: 0.05% chlorhexidine and 0.05% cetyl‐pyridinium chloride mouth rinse
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 47
Study: 17401796

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia using 0.5% hyperbaric bupivacain from L3-4 intervertebral space
Number of subjects: 50
Study: 16365255

Group type: EXPERIMENTAL
Intervention: Targeted UV-B phototherapy (1 to 6 multiples of MEDs)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Targeted UV-B phototherapy (2 to 6 MEDs)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Targeted UV-B phototherapy
Number of subjects: 14
Study: 12014782

Group type: EXPERIMENTAL
Intervention: Manual-based bereavement group intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 75
Study: 10594420

Group type: EXPERIMENTAL
Intervention: Acupuncture pretreatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard anaesthetic without acupuncture
Number of subjects: 42
Study: 7600477

Group type: EXPERIMENTAL
Intervention: Case management by an advanced practice nurse (APN)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Non-case management
Number of subjects: 78
Study: 1977430

Group type: EXPERIMENTAL
Intervention: Xamoterol (200 mg twice daily)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Xamoterol
Number of subjects: 13

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 502530

Group type: EXPERIMENTAL
Intervention: Regression equation for males (Y=0.503+0.0269 X)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Regression equation for females (Y=0.341+0.0291 X)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Total group regression equation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cooper's equation (Y=0.3138+0.0278 X)
Number of subjects: 150
Study: 31800526

Group type: EXPERIMENTAL
Intervention: Mediational Intervention for Sensitizing Caregivers (MISC) training emphasizing cognitive stimulation/enrichment
Number of subjects: 216

Group type: COMPARATOR
Intervention: Health/nutrition/development program (UCOBAC)
Number of subjects: 216
Study: 31209821

Group type: EXPERIMENTAL
Intervention: MSDE intervention (n=46)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (n=43)
Number of subjects: 89
Study: 28620678

Group type: EXPERIMENTAL
Intervention: Lifestyle improvement program for 4 months
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 150
Study: 26433117

Group type: EXPERIMENTAL
Intervention: Blended electronic advanced life support (e-ALS) course
Number of subjects: 2848

Group type: COMPARATOR
Intervention: Traditional face-to-face advanced life support course
Number of subjects: 2848

Group type: EXPERIMENTAL
Intervention: e-ALS course
Number of subjects: 2848
Study: 24491070

Group type: EXPERIMENTAL
Intervention: Early intervention
Number of subjects: 137

Group type: COMPARATOR
Intervention: Assessment-only (treatment as usual)
Number of subjects: 137
Study: 22971505

Group type: EXPERIMENTAL
Intervention: Group A (gender-determined bent length)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Group B (TMD-determined bent length)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Group C (TID-determined bent length)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 246
Study: 19650856

Group type: EXPERIMENTAL
Intervention: Target hematocrit range of 42 +/- 3%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Partial correction in a range of 30 +/- 3%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal-hematocrit group in NHCT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High doses of erythropoietic stimulating agents and/or intravenous iron
Number of subjects: 0
Study: 16814449

Group type: EXPERIMENTAL
Intervention: Oral continuous combined therapy (Group A, n = 31)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Transdermal sequential hormone replacement therapy (Group B, n = 30)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (Group C, n = 30)
Number of subjects: 110
Study: 14684777

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler (TCD)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS)
Number of subjects: 57
Study: 12003685

Group type: EXPERIMENTAL
Intervention: Pharmacologic treatment with antidepressants for patients with COPD and depression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 0
Study: 10092716

Group type: EXPERIMENTAL
Intervention: Lidocaine iontophoresis (1 mL of 2% lidocaine with 1:100,000 epinephrine)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (1 mL of 0.9% saline solution with 1:100,000 epinephrine)
Number of subjects: 47
Study: 8548102

Group type: EXPERIMENTAL
Intervention: Generalized additive models
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Survival models
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Binary outcome models
Number of subjects: 0
Study: 2256875

Group type: EXPERIMENTAL
Intervention: Phenytoin (anticonvulsant dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7362955

Group type: EXPERIMENTAL
Intervention: Single preoperative dose of cotrimoxazole and metronidazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multiple doses of cotrimoxazole and metronidazole for 5 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Single dose group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multiple doses group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patients with transphincteric colo-anastomoses
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patients with anastomosis from within the abdomen
Number of subjects: 60
Study: 31512832

Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation after tooth extraction (Bio‐Oss bone powder implanted in alveolar fossa and fixed with surface free gingival graft suture)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment after tooth extraction (Control group)
Number of subjects: 30
Study: 27820930

Group type: EXPERIMENTAL
Intervention: Percutaneous angioplasty and stenting (PTAS) plus aggressive medical management (AMM)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Aggressive medical management (AMM) alone
Number of subjects: 451
Study: 26073397

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE) 4 g/day
Number of subjects: 427

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study: 24616241

Group type: EXPERIMENTAL
Intervention: Obesity prevention program participation
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Peer influence
Number of subjects: 557
Study: 23002274

Group type: EXPERIMENTAL
Intervention: Dermal protection (protective clothing)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Powered air-purifying respirator (PAPR)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Biodiesel substitution (100% biodiesel)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline (normal conditions)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Application temperature of HMA
Number of subjects: 12
Study: 19040797

Group type: EXPERIMENTAL
Intervention: Gonyautoxin (50 micrograms) infiltrated in ten pain trigger points, 200 microlitres per site.
Number of subjects: 27
Study: 18055959

Group type: EXPERIMENTAL
Intervention: Reducing patient-rated unmet need
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Reducing staff-rated unmet need
Number of subjects: 101
Study: 15352982

Group type: EXPERIMENTAL
Intervention: Z-Dex (idarubicin and dexamethasone)
Number of subjects: 106

Group type: COMPARATOR
Intervention: VAD (vincristine, adriamycin and dexamethasone)
Number of subjects: 106
Study: 11264441

Group type: EXPERIMENTAL
Intervention: Transient chemoreceptor stimuli (100% O(2), 15% O(2), or 3% CO(2))
Number of subjects: 46
Study: 11716207

Group type: EXPERIMENTAL
Intervention: Formoterol (9 microg per inhalation, total cumulative dose of 27 microg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Formoterol (27 microg)
Number of subjects: 20